CrownBio’s validated syngeneic tumor models support the transition into the clinic.
Our syngeneic model data, including RNAseq, tumor growth curve, and response to standard of care agents are available within MuBase®. Not registered yet?
Want to interrogate your compound's PD effect or efficacy in vivo?
Ask us about MuScreen™, our large scale staggered syngeneic screening platform to fast track strategies.
Fill in the form and we will be in touch soon!